Data, obtained from a Freedom of Information (FOI) request, indicates that 17% of acute trusts (there were 87 that did respond) offer the full range of non-pharmaceutical therapies suggested by NICE guidance, while less than 45% offer one or more such non-drug therapies. Perhaps surprisingly, 39% of the responding Trusts report that they do not offer any non-pharmacological therapies for agitation, aggression and similar BPSD.
Robinson, J. (2020). Almost 40% of hospitals do not offer non-drug therapies to distressed dementia patients. [Online]: The Pharmaceutical Journal, February 20th 2020.